Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Hormone Therapy as A New Hope for Achondroplasia Patients

View through CrossRef
Achondroplasia is a disorder of child bone growth due to gene mutation of growth factor receptor. Short stature is a major problem. Efforts to increase height are still a challenge. The method performed so far is the lengthening of the limbs with various complications and risks of re-surgery. A promising new alternative without surgery is the administration of growth hormone therapy. This review aims to find out the safety and effectiveness of hormone therapy. The review method used is a narrative review. The review results showed that growth hormone therapy is safe and effective. The review concludes that growth hormone therapy has been proven to be safe and effective in increasing the height of achondroplasia patients.
Title: Hormone Therapy as A New Hope for Achondroplasia Patients
Description:
Achondroplasia is a disorder of child bone growth due to gene mutation of growth factor receptor.
Short stature is a major problem.
Efforts to increase height are still a challenge.
The method performed so far is the lengthening of the limbs with various complications and risks of re-surgery.
A promising new alternative without surgery is the administration of growth hormone therapy.
This review aims to find out the safety and effectiveness of hormone therapy.
The review method used is a narrative review.
The review results showed that growth hormone therapy is safe and effective.
The review concludes that growth hormone therapy has been proven to be safe and effective in increasing the height of achondroplasia patients.

Related Results

Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
An overview of the International Consensus Statement on achondroplasia
An overview of the International Consensus Statement on achondroplasia
Abstract Achondroplasia is the most common form of short-limbed short stature of genetic origin. Most people with achondroplasia live fully independent, productiv...
The Role of Thyroid Hormone in Neuronal Protection
The Role of Thyroid Hormone in Neuronal Protection
Abstract Thyroid hormone is essential for brain development and brain function in the adult. During development, thyroid hormone acts in a sp...
Circulatory CNP Rescues Craniofacial Hypoplasia in Achondroplasia
Circulatory CNP Rescues Craniofacial Hypoplasia in Achondroplasia
Achondroplasia is the most common genetic form of human dwarfism, characterized by midfacial hypoplasia resulting in occlusal abnormality and foramen magnum stenosis, leading to se...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Exploring the Efficacy of Once and Twice Weekly Thyroxine Dosing: A Promising Approach for Hypothyroidism Management
Exploring the Efficacy of Once and Twice Weekly Thyroxine Dosing: A Promising Approach for Hypothyroidism Management
Abstract Introduction Hypothyroidism is a common endocrine disorder, in which the management involves daily intake of thyroxine. However, adherence to a daily medication regimen po...

Back to Top